Cargando…
The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage
Erythropoietin (EPO) has been well known as a hematopoietic cytokine over the past decades. However, recent reports have demonstrated that EPO plays a neuroprotective role in the central nervous system, and EPO has been considered as a therapeutic target in neurodegenerative diseases such as ischemi...
Autores principales: | Yoo, Seung-Jun, Cho, Bongki, Lee, Deokho, Son, Gowoon, Lee, Yeong-Bae, Soo Han, Hyung, Kim, Eunjoo, Moon, Chanil, Moon, Cheil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596568/ https://www.ncbi.nlm.nih.gov/pubmed/28817120 http://dx.doi.org/10.1038/cddis.2017.381 |
Ejemplares similares
-
Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection
por: Cho, Bongki, et al.
Publicado: (2021) -
Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
por: Hernández, Carolina Castillo, et al.
Publicado: (2017) -
Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke
por: Asadi, Bahador, et al.
Publicado: (2013) -
The neuroprotective effect of recombinant human erythropoietin via an antiapoptotic mechanism on hypoxic-ischemic brain injury in neonatal rats
por: Kim, Moon Sun, et al.
Publicado: (2010) -
Erythropoietin: a multimodal neuroprotective agent
por: Byts, Nadiya, et al.
Publicado: (2009)